We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Cell Replacement Therapy – A Promising Treatment for Age-Related Macular Degeneration
Industry Insight

Here we share a Q&A with Brian Culley, CEO of Lineage Cell Therapeutics. In this interview, Brian discusses age-related macular degeneration and retinal pigment epithelium transplant therapy.

Read More

Collaboration Is the Key to Efficient Product Development
Industry Insight

Outsourcing certain aspects of experimental work to biotech companies with vital experience in relevant areas can help to advance products more rapidly, accelerating time-to-market and ensuring success.

Read More

Bringing Speed and Simplicity to SEM-EDS Analysis
Industry Insight

While many researchers combine scanning electron microscopy (SEM) with energy dispersive X-ray spectroscopy (EDS) to examine materials for defects at the micro-scale, the process is often viewed as slow and complex. Fortunately, however, advances in SEM-EDS analysis are bringing a new level of speed and simplicity to failure analysis.

Read More

How Will Genome UK Securely Handle 150 Petabases of Genomic Data?
Industry Insight

Genomic data company PetaGene recently sounded a warning that Genome UK, the UK government’s recently announced genomic healthcare strategy, needs to address important data handling challenges to maintain public trust. To find out more, Technology Networks spoke to PetaGene’s co-founder and chief commercial officer, Vaughan Wittorff, PhD, and co-founder and chief executive officer, Dan Greenfield, PhD.

Read More

Exploring Trends in Drug and Alcohol Testing
Industry Insight

With demand for workplace drug and alcohol testing growing in many countries and the increasing liberalization of drug laws across the world, the market is predicted to grow considerably over the next decade. Here we share a Q&A with John Wick, CEO of Cansford Laboratories, who pioneered the use of hair testing in the UK around 25 years ago.

Read More

Exploring the Challenges and Opportunities of Harvesting CTCs
Industry Insight

In a recent study, CTCs were harvested to investigate the causes of brain metastasis in non-small cell lung cancer patients. We spoke to Andrew Newland, CEO, ANGLE, to learn more about the study, the challenges of harvesting CTCs and how the Parsortix system overcomes some of these challenges.

Read More

A Vaccine for Alzheimer’s Disease? An Interview With AC Immune’s Prof Andrea Pfeifer
Industry Insight

Swiss biopharma AC Immune has made targeting Alzheimer’s disease, the leading form of dementia, a top priority. 2020 has brought mixed news for AC Immune's therapeutics, including promising safety data for their anti-Alzheimer's disease vaccine candidate. To discuss AC Immune’s work, Technology Networks spoke to CEO Prof. Andrea Pfeifer.

Read More

Capturing the Transcriptome and the Epigenome Simultaneously in Single Cells
Industry Insight

How do we take our understanding of the different stages of the omics cascade to the next level? We analyze them simultaneously. With the recent launch of its Chromium Single Cell Multiome ATAC + Gene Expression solution, 10x Genomics is making advances towards that goal. Technology Networks spoke with Ben Hindson to learn more.

Read More

Making Mushrooms: How Psilocybin Is Extracted and Used in Mental Health Research
Industry Insight

Psilocybin’s emergence as a valuable tool for mental health research has been a huge breakthrough for the field. But how do researchers get their hands on this heavily regulated substance? Technology Networks talked to Tim Moore, CEO of Havn Life Sciences, a company that produces psychoactive compounds from plants and fungi, to find out more.

Read More

Overcoming the Challenges of Manufacturing Therapeutic Mesenchymal Stem Cells
Industry Insight

Technology Networks had the pleasure of speaking with Ross Macdonald, CEO of Cynata Therapeutics, to learn more about the challenges of manufacturing therapeutic MSCs and how the Cymerus technology overcomes these.

Read More

 
Advertisement